U.S. authorizes Merck pill as second at-home COVID-19 treatment
Go back to U.S. authorizes Merck pill as second at-home COVID-19 treatment| Merck & Co. (NYSE: MRK) | Delayed: 135.17 -0.8 (0.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $135.97 | 52 Week High | $65.46 | |||
| Open | $137.24 | 52 Week Low | $47.97 | |||
| Day High | $137.98 | P/E | 91.95 | |||
| Day Low | $134.88 | EPS | $1.47 | |||
| Volume | 10,284,223 | |||||
